ABIVAX

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ABIVAX was filed as Word mark on 10/31/2022 at the World Intellectual Property Organization.

Trademark Details Last update: May 26, 2023

Trademark form Word mark
File reference 1701608
Countries Australia Brazil Canada China Cuba France United Kingdom India Japan South Korea Mexico
Base trademark EU No. 018753583, August 26, 2022
Application date October 31, 2022
Expiration date October 31, 2032

Trademark owner

5 rue de la Baume
F-75008 Paris
FR

Trademark representatives

160 Queen Victoria Street London EC4V 4QQ GB

goods and services

05 Pharmaceutical preparations for the prevention and treatment of oncologic, autoimmune, inflammatory, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, gastrointestinal, musculoskeletal, viral, and fungal disease and other related diseases; vaccines for human and veterinary use; adjuvants for use with vaccines
42 Pharmaceutical research and development; drug development and discovery services; medical and scientific research; providing medical and scientific research information services; research services in the field of pharmaceuticals; laboratory research services relating to pharmaceuticals

Trademark history

Date Document number Area Entry
May 19, 2023 2023/21 Gaz AU Rejection
May 15, 2023 2023/20 Gaz CN Rejection
May 15, 2023 2023/20 Gaz FR Rejection
March 13, 2023 2023/11 Gaz GB Rejection
October 31, 2022 2022/48 Gaz EM Registration

ID: 141701608